Related Experiment Videos
[Role of macrophages in the antitumor action of the recombinant probiotic Subalin]
N V Litviakov1, N V Cherdyntseva, V A Beliavskaia
1Research Institute of Oncology, Research Center, Russian Academy of Medical Science, Siberian Branch, Tomsk.
Abstract:
Course administration of the recombinant probiotic subalin was shown to significantly potentiate the cytotoxic action of macrophages from healthy and tumor-bearing mice against mastocytoma P-815 cells and syngeneic target cells of lung sarcoma of Lewis. Carrageenan, an inhibitor of macrophage activity, significantly cut down the antimetastaic effect of subalin. The crucial role of macrophages in the mechanism of this function of the drug is discussed.
Insights
Recombinant probiotic subalin enhances macrophage cancer-fighting activity in mice. This antimetastatic effect is dependent on macrophage function, as shown by inhibition studies.
Area of Science:
- Immunology
- Microbiology
- Oncology
Context:
- The study investigates the immunomodulatory effects of probiotics in cancer therapy.
- Macrophage-mediated cytotoxicity is a key component of the innate immune response against tumors.
Purpose:
- To evaluate the efficacy of recombinant probiotic subalin in potentiating macrophage-mediated anti-cancer activity.
- To elucidate the role of macrophages in the antimetastatic mechanism of subalin.
Summary:
- Administration of recombinant probiotic subalin significantly enhanced the cytotoxic activity of macrophages against mastocytoma P-815 and Lewis lung sarcoma cells in mice.
- The antimetastatic effect of subalin was significantly reduced by carrageenan, a known inhibitor of macrophage activity, highlighting the critical role of macrophages.
Impact:
- These findings suggest that subalin could be a promising agent for cancer immunotherapy by activating macrophages.
- Understanding the mechanism of action provides a basis for developing novel probiotic-based cancer treatments.